Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.
Thomas WilkeAnna-Katharina MeineckeBernhard SchaeferSandra BuchwaldDaniel ErikssonSabrina MüllerPublished in: Cardiology research and practice (2019)
Patients primarily prefer a once-daily NOAC regimen. Individual preferences should be considered for the treatment of AF patients as this may result in improved treatment adherence and consequently better effectiveness and safety in routine clinical practice.
Keyphrases
- end stage renal disease
- oral anticoagulants
- atrial fibrillation
- clinical practice
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- type diabetes
- physical activity
- decision making
- brain injury
- skeletal muscle
- case report
- patient reported
- blood brain barrier
- patient reported outcomes
- insulin resistance
- weight loss